TrialMedical oncology (Northwood, London, England)2005

The safety of full-dose chemotherapy with secondary prophylactic granulocyte colony stimulating factor (G-CSF) following a prior cycle with febrile neutropenia.

Nissim Haim et al.PubMed ↗Publisher ↗

No numbers read from the abstract.